Scholarlink

<p>Oral fungal microbiota plays an important role in many diseases, however, the role of oral fungal microorganisms in the development of patients infected with Omicron has not been reported. A total of 963 tongue coating samples were prospectively included in this study, and finally 336 samples from patients infected Omicron variant (PIOV), 234 samples from recovered patients infected with Omicron (RP), 71 samples from patients infected original strain of Severe Acute Respiratory Syndrome Coronavirus 2 (<i>SARS-CoV-2</i>) (PIOS), 299 samples from healthy controls (HC) completed internal transcribed spacer (ITS) sequencing after screening and quality control. By comparing the difference of oral fungal microorganisms between PIOV, RP and HC, we found that with the recovery of PIOV, their oral fungal microecological diversity increased gradually. Besides, at the species level, there were 24 oral fungal species such as <i>Zanclospora_jonesii</i> increased gradually, while there were 24 oral fungal species such as <i>Saccharomyces_cerevisiae</i> decreased gradually. In addition, by comparing PIOS and PIOV, we found that the alpha diversity of oral fungal microorganisms in PIOV was significantly lower than PIOS and the main species of the two groups were different. At the same time, we randomly divided PIOV and HC into training and validation set. Based on random forest model and five-fold cross-validation, we identified three optimal microbial markers of oral fungi and constructed a diagnostic model of PIOV. The area under the curve (AUC) value of PIOV group was 99.01% in discovery phase and 97.84% in verification phase. In summary, based on large-scale samples, this study is the first to elucidate the characteristics of oral fungal microbiota changes during PIOV recovery and establish a supplemental non-invasive diagnostic model for PIOV based on the oral fungal microbiome.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dynamic alterations of oral fungal microbiota in Omicron infected patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月14日

查看全文
  • Yarong Ma,
  • Shanshuo Liu,
  • Guizhen Zhang,
  • Liwen Liu,
  • Junyi Sun,
  • Yawen Zou,
  • Ying Sun,
  • Lei Li,
  • Benchen Rao,
  • Haiyu Wang,
  • Zujiang Yu,
  • Zhigang Ren

摘要

Oral fungal microbiota plays an important role in many diseases, however, the role of oral fungal microorganisms in the development of patients infected with Omicron has not been reported. A total of 963 tongue coating samples were prospectively included in this study, and finally 336 samples from patients infected Omicron variant (PIOV), 234 samples from recovered patients infected with Omicron (RP), 71 samples from patients infected original strain of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (PIOS), 299 samples from healthy controls (HC) completed internal transcribed spacer (ITS) sequencing after screening and quality control. By comparing the difference of oral fungal microorganisms between PIOV, RP and HC, we found that with the recovery of PIOV, their oral fungal microecological diversity increased gradually. Besides, at the species level, there were 24 oral fungal species such as Zanclospora_jonesii increased gradually, while there were 24 oral fungal species such as Saccharomyces_cerevisiae decreased gradually. In addition, by comparing PIOS and PIOV, we found that the alpha diversity of oral fungal microorganisms in PIOV was significantly lower than PIOS and the main species of the two groups were different. At the same time, we randomly divided PIOV and HC into training and validation set. Based on random forest model and five-fold cross-validation, we identified three optimal microbial markers of oral fungi and constructed a diagnostic model of PIOV. The area under the curve (AUC) value of PIOV group was 99.01% in discovery phase and 97.84% in verification phase. In summary, based on large-scale samples, this study is the first to elucidate the characteristics of oral fungal microbiota changes during PIOV recovery and establish a supplemental non-invasive diagnostic model for PIOV based on the oral fungal microbiome.